Missing/wrong data?
Log in to edit
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial
scientific article published on 29 September 2019
Author/s
author: Pierfranco Conte, Patrick Neven, George Sledge, Norikazu Masuda, Masakazu Toi
Work details
Publication date
September 29, 2019
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.